Document is current

Article History

Received: 30 September 2024

Accepted: 26 January 2025

First Online: 22 February 2025

Declarations

:

: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki and adhered to ethical guidelines for medical research involving human subjects. Ethical approval for the study was obtained from the Ethic Committees in the participating sites, as listed below: All participants provided informed consent prior to their inclusion in the study. They were thoroughly informed about the study’s purpose, procedures, potential risks, and benefits. Participants were also assured of their right to withdraw from the study at any time without any repercussions. Consent was documented in written form, and copies of the consent documents are securely stored in accordance with institutional policies.In cases where participants were unable to provide consent personally, legal guardians or authorized representatives provided consent on their behalf. Additionally, confidentiality and anonymity of the participants’ data were strictly maintained.

: Not applicable.

: YG: Research funding from: Abbott, Boston Scientific, General Electric, Veryan, WL Gore.Personal fees and grants from: Abbott, Bard, Biotronik, Boston Scientific, Cook, General Electric, Medtronic, Penumbra, Terumo, Veryan, WL Gore (medical advisory board, educational course, speaking).TZ: No conflict of interest.KD: Grant/Research from: Abbott, Biotronik, iVascular, Terumo. Consultancy from: Abbott, BD, Bently, Biotronik, Boston Scientific, Cook, GE Healthcare.MD: No conflict of interest.